Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)

Psoriasis is a common, disabling, chronic, relapsing, inflammatory disorder of the skin with a worldwide prevalence of 2–3 % in which adherence to treatment is often poor. The majority of individuals have limited disease that is being treated with topical medication according to existing guidelines....

Full description

Bibliographic Details
Main Authors:	Reich, Kristian, Mrowietz, Ulrich, Karakasili, Eleni, Zschocke, Ina
Format:	Online
Language:	English
Published:	Springer Berlin Heidelberg 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139584/

id	pubmed-4139584
recordtype	oai_dc
spelling	pubmed-41395842014-08-26 Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP) Reich, Kristian Mrowietz, Ulrich Karakasili, Eleni Zschocke, Ina Original Paper Psoriasis is a common, disabling, chronic, relapsing, inflammatory disorder of the skin with a worldwide prevalence of 2–3 % in which adherence to treatment is often poor. The majority of individuals have limited disease that is being treated with topical medication according to existing guidelines. Adherence rates are lower for topical compared with systemic treatment. Low medication adherence is a major problem for patients with chronic disorders as it results in suboptimal treatment outcomes, increased risk for development of concomitant diseases, inefficient use of health resources and considerable losses to society. However, to date no adherence-enhancing intervention has been developed for psoriasis patients under topical treatment. In this article, we report the development of the topical treatment optimization program (TTOP). The TTOP intervention aims to improve the information given to the patients and to result in an engaged patient–physician relationship. Application of the TTOP intervention in daily clinical practice may lead to a significant increase of adherence and the successful management of psoriasis and other chronic skin disorders. Springer Berlin Heidelberg 2014-06-04 2014 /pmc/articles/PMC4139584/ /pubmed/24895177 http://dx.doi.org/10.1007/s00403-014-1475-5 Text en © The Author(s) 2014 Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Reich, Kristian Mrowietz, Ulrich Karakasili, Eleni Zschocke, Ina
spellingShingle	Reich, Kristian Mrowietz, Ulrich Karakasili, Eleni Zschocke, Ina Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)
author_facet	Reich, Kristian Mrowietz, Ulrich Karakasili, Eleni Zschocke, Ina
author_sort	Reich, Kristian
title	Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)
title_short	Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)
title_full	Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)
title_fullStr	Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)
title_full_unstemmed	Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)
title_sort	development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (ttop)
description	Psoriasis is a common, disabling, chronic, relapsing, inflammatory disorder of the skin with a worldwide prevalence of 2–3 % in which adherence to treatment is often poor. The majority of individuals have limited disease that is being treated with topical medication according to existing guidelines. Adherence rates are lower for topical compared with systemic treatment. Low medication adherence is a major problem for patients with chronic disorders as it results in suboptimal treatment outcomes, increased risk for development of concomitant diseases, inefficient use of health resources and considerable losses to society. However, to date no adherence-enhancing intervention has been developed for psoriasis patients under topical treatment. In this article, we report the development of the topical treatment optimization program (TTOP). The TTOP intervention aims to improve the information given to the patients and to result in an engaged patient–physician relationship. Application of the TTOP intervention in daily clinical practice may lead to a significant increase of adherence and the successful management of psoriasis and other chronic skin disorders.
publisher	Springer Berlin Heidelberg
publishDate	2014
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139584/
_version_	1613126027476729856

Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)

Similar Items